Back to Clinical Trials
Phase 2Recruiting

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sponsored by Eli Lilly and Company

About this study

The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.

Where this study is enrolling (5)

  • The Institute for Liver Health II dba Arizona Liver Health-Tucson

    Tucson, Arizona

    I'm interested

  • Headlands Research - Scottsdale

    Scottsdale, Arizona

    I'm interested

  • The Institute for Liver Health II dba Arizona Clinical Trials - Mesa

    Chandler, Arizona

    Call 480-360-4000

    This research site can be reached directly by phone. Call to ask about this study.

    Create a free account to get updates on similar Clinical Trials for your conditions.

  • Great Lakes Clinical Trials - Ravenswood

    Chicago, Illinois

    I'm interested

  • PlanIt Research, PLLC

    Houston, Texas

    I'm interested
Who can participate

Inclusion criteria

  • ✓See Master Protocol CWMM (NCT06143956) for inclusion criteria

Exclusion criteria

  • ✕In addition to exclusion criteria in Master Protocol CWMM (NCT06143956):
  • ✕Have type 1 diabetes or type 2 diabetes
  • ✕Have an ongoing history of bradyarrhythmia and/or sinus bradycardia
  • ✕Have an elevated resting pulse rate (greater than 100 bpm) or reduced resting pulse rate (less than 60 bpm)
  • ✕Have a history of acute or chronic pancreatitis
  • ✕All concomitant medications should be at a stable dose for at least 3 months prior to screening

Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.